close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

819.38 -7.19 (-0.87%)
Official Closing Price Updated: 7:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
Upcoming Earnings Calls This Week: August 4th - August 10th, 2025
This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial... 
Via MarketMinute
Topics Artificial Intelligence Economy
Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
Indianapolis, IN – Shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) experienced a significant downturn, plummeting over 10% in premarket trading and continuing to slide throughout the... 
Via MarketMinute
Topics Economy
Eli Lilly’s Oral Obesity Drug Leads To Over 12% Weight Loss In Late-stage Study
Via Stocktwits
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Intel Stock Falls After Trump Says CEO 'Must Resign'
Intel stock fell after President Trump said CEO Lip-Bu Tan "must resign," saying he is "highly conflicted." 
Via Investor's Business Daily
Topics Government Law Enforcement
Thursday's session: gap up and gap down stock in the S&P500 index
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors
Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure, and Terns amid promising trial updates. 
Via Benzinga
Eli Lilly (LLY) Q2 Revenue Jumps 38%
Via The Motley Fool
Topics Intellectual Property
Lilly Shares Tumble As Weak Weight-Loss Pill Data Overshadows Strong Earnings
Eli Lilly shares plunged in premarket trading after disappointing results from its new weight-loss drug overshadowed strong second-quarter results and raised full-year guidance. 
Via Talk Markets
Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge.
An analyst called the unexpected flop a "once-in-a-blue-moon" occasion for Eli Lilly's dominant weight-loss franchise. 
Via Investor's Business Daily
Eli Lilly's Closely Watched Obesity Pill Orforglipron Shows Around 12% Weight Loss But Trails Novo Nordisk
Eli Lilly shares fell after orforglipron's Phase 3 data showed less weight loss than rival drugs, despite a strong Q2 earnings beat and raised guidance. 
Via Benzinga
Topics Earnings
These S&P500 stocks are moving in today's pre-market session
Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday? 
Via Chartmill
Eli Lilly & Co (NYSE:LLY) Reports Strong Q2 2025 Earnings Beat but Faces Pre-Market Decline Amid Market Skepticism
Eli Lilly (LLY) beat Q2 2025 earnings with strong Mounjaro & Zepbound demand, but shares fell 13% pre-market amid profit-taking and high expectations. Raised guidance signals confidence. 
Via Chartmill
Topics Earnings
Peloton Reportedly Laying Off 6% Of Its Staff In Another Round Of Job Cuts To Trim Expenses
According to a CNBC report, the company plans to reduce run-rate expenses by another $100 million in fiscal year 2026, on top of the $200 million it cut in fiscal 2025, half of which will come from... 
Via Stocktwits
Topics Workforce
Dow Futures Rise As Trump’s Reciprocal Tariff Deadline Kicks In: AAPL, NVDA, INTC, LLY, SRPT Among Stocks To Watch
Via Stocktwits
Topics Government Stocks
Stock Market Today: US Futures Rise Amid Russia Peace Talk Update—Investors Await Eli Lilly, Block Earnings
U.S. stock futures rose on Thursday after ending higher on Wednesday. Futures of major benchmark indices were up. 
Via Benzinga
Nvidia Stake, Vision Funds Boost Softbank’s Q1 Results As Masayoshi Son’s Investment Company Looks To Ramp Up AI Bets
Softbank recorded an investment gain of 559.7 billion yen, helped by gains from its stake in Nvidia and strong performances by its SoftBank Vision Funds. 
Via Stocktwits
Topics Artificial Intelligence Government
Nasdaq, S&P 500 Futures Climb Despite Trump Tariff Rollout — Spotlight On Jobs Data, Eli Lilly, Warner Bros. Earnings
Via Stocktwits
Topics Government Stocks
Nasdaq Surges Over 1% Amid Jump In Apple Shares: Fear & Greed Index Remains In 'Neutral' Zone
 
Via Benzinga
Eli Lilly, ConocoPhillips And 3 Stocks To Watch Heading Into Thursday
 
Via Benzinga
Why Novo Nordisk Stock Slipped Today
The Danish pharmaceutical company is fighting a competitive war on several fronts. 
Via The Motley Fool
Topics Lawsuit
Is It Time to Buy Biotech Stocks?
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech? 
Via The Motley Fool
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
Eli Lilly and Amgen are suing HHS over 340B certifications, claiming ineligible clinics cost them millions in lost revenue. 
Via Benzinga
Topics Lawsuit
LifeMD Stock Plummets 40%. Why Weight Loss Isn't Just A Gimme.
The company is struggling with several headwinds as it works to develop its obesity plan. 
Via Investor's Business Daily
Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy
The company says it's working to ensure patients only receive semaglutide produced by Novo Nordisk. 
Via Investor's Business Daily
Topics Earnings
A Rough Day for "Dividend Knights"
Between battered industries and overlooked opportunities, plenty of dividend-paying companies have slipped. 
Via The Motley Fool
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings
Eli Lilly offers an annual dividend yield of 0.78%. So, how can investors exploit its dividend yield to pocket a regular $500 monthly? 
Via Benzinga
Novo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff Pressure
The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance. 
Via Stocktwits
Topics Government World Trade
Trump Threatens Pharma With Potential 250% Tariffs In 18 Months: 'We Want Pharmaceuticals Made In Our Country'
President Donald Trump has indicated the possibility of imposing tariffs on imported pharmaceuticals that could rise up to 250%, indicating the highest rate he has proposed so far. 
Via Benzinga
Topics Government World Trade
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today